Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Progranulin (PGRN) fragments and derivatives for treatment or alleviation of lysosomal storage diseases

Progranulin (PGRN) fragments and derivatives for treatment or alleviation of lysosomal storage diseases

US Patent 11390656 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-carrier on-off keying communications2025
Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal 2019
Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal 2019
Peptides targeting TNF family receptors and antagonizing TNF action, composition2014
Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in c2013
Peptides targeting TNF family receptors and antagonizing TNF action, composition2013
Methods for using GEP, a chondrogenic growth factor and target in cartilage diso2011